A $416 Million Hit to Union Workers: New Research Highlights How the 340B Program Drives Up Costs for Taft-Hartley Plans
A recent study found that a little-known federal program may be driving up union healthcare costs by as much as $416 million per year. The 340B program was created more than 30 years ago to help safety-net providers serve low-income communities by offering prescription drugs at steep discounts. Over time, however, the program has expanded […]
Foreign Reference Pricing Threatens Union Jobs, American Global Leadership
FOR IMMEDIATE RELEASEAugust 7, 2025 Importing foreign prices would undermine life science innovation, eliminate union jobs, and cede ground to China The Pharmaceutical Industry Labor-Management Association (PILMA) expresses deep concern over recent White House actions that aim to implement a “Most Favored Nation” (MFN) pricing policy for prescription drugs. This misguided approach poses a serious […]
Evaluating the Role of 340B in Managing Healthcare Costs for Taft-Hartley Plans
Download Taft Hartley Plans PDF Download the one pager In the United States, unlike other countries, the net prices of medications are generally treated as trade secrets; with information regarding a drug’s net price amount not readily available in the public domain. Since the passage of the anti-kickback statute and the establishment of the various […]
Letter to HELP Committee on PBMs
July 31, 2025 The Honorable Bill Cassidy, Chairman Senate Committee on Health, Education, Labor and Pensions United States Senate Washington, DC 20510 The Honorable Bernie Sanders, Ranking Member Senate Committee on Health, Education, Labor and Pensions United States Senate Washington, DC 20510 Dear Chairman Cassidy and Ranking Member Sanders, On behalf of the Pharmaceutical Industry Labor-Management Association (PILMA) […]
PILMA – IUOE LOCAL 150 FACILITY TOUR
IUOE Local 150 hosted a facility tour to highlight its long-standing partnership with the biopharmaceutical industry and skilled union labor’s critical role in building and supporting life sciences infrastructure. For years, Local 150 has worked alongside pharmaceutical companies to construct the laboratories, manufacturing plants, and corporate campuses where cutting-edge medical innovation happens. The tour showcased […]
Mental Health Lunch and Learn with UA Local 9
PILMA partnered with UA Local 9 to host a “Lunch & Learn” event focused on mental health. In attendance were local union business managers and staff from the Ironworkers, UA, IBEW, IUOE, as well as representatives from Otsuka, and the American Foundation for Suicide Prevention (AFSP). The event produced insightful and vulnerable conversations among the […]
Most-Favored-Nation Drug Pricing: A Threat to American Workers and Innovation
Most-Favored-Nation (MFN) foreign reference pricing is the wrong approach to lowering drug costs. It will hurt patients, endanger good-paying union jobs, and hand the strategic advantage to China—precisely when manufacturing reshoring momentum is building across the country. Devastating Consequences for American Workers The U.S. biopharmaceutical industry supports nearly 5 million jobs nationwide and contributes moreto […]
RESOLUTION Concerning the Misuse and Needed Reform of the Federal 340B Drug Pricing Program
June 4, 2025 WHEREAS, the Pharmaceutical Industry Labor-Management Association (PILMA) is a coalition of labor unions and companies in the pharmaceutical industry united to grow the economy, create high-quality union jobs, and foster medical innovation; and WHEREAS, PILMA’s mission includes advocating for policies that support innovation, fair labor practices, and access to affordable, high-quality healthcare […]
PRESS RELEASE New Study Demonstrates Critical Role of American Workers in Building Life-Saving Medicine Infrastructure
June 17, 2025 Research shows the U.S. pharmaceutical industry generated 65 million labor hours and $2.6 billion in wages for skilled union workers who built and maintained advanced pharmaceutical manufacturing facilities across 18 states over the past five years. The Pharmaceutical Industry Labor-Management Association (PILMA) today released groundbreaking research demonstrating the pharmaceutical and biotech industries’ […]
Statement on Executive Order
PILMA Urges Congress to Address IRA’s “Pill Penalty” Following Executive Action April 17, 2025 Bipartisan EPIC Act offers solution to protect patient access, pharmaceutical The Pharmaceutical Industry Labor-Management Association (PILMA) welcomes renewed attention to the harmful impacts of the Inflation Reduction Act’s so-called “pill penalty,” highlighted in the April 15 Presidential Executive Order. The pill […]